PFGIA
IBRX icon

Patriot Financial Group Insurance Agency’s ImmunityBio IBRX Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-19
Closed – – 2135
2021
Q4 		$0 Hold
19
– – ﹤0.01% 2196
2021
Q3 		$0 Buy
+19
New +$209 ﹤0.01% 2188

Other funds holding IBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 14.43% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Patriot Financial Group Insurance Agency's IBRX Position: Q1 2022 in Review

Patriot Financial Group Insurance Agency sold out of ImmunityBio (IBRX) in Q1 2022, closing a stake of 19 shares.

Patriot Financial Group Insurance Agency first reported a position in IBRX in Q3 2021 and held it in 2 quarters. The position peaked at $0 in Q4 2021. 149 funds tracked by Wall St. Rank hold IBRX as of Q1 2022.

  • Patriot Financial Group Insurance Agency reported no remaining ImmunityBio position as of Q1 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 19 ImmunityBio shares in Q1 2022.
  • Patriot Financial Group Insurance Agency first reported a position in ImmunityBio in Q3 2021 and held it in 2 quarters.
  • Patriot Financial Group Insurance Agency's ImmunityBio position peaked at $0 in Q4 2021.
  • 149 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q1 2022, filed 11 May 2022.